Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
This content is provided by Henning Schneider
Dr. Henning C. Schneider served as the Global Co-Chair of one of the firm's Industry Groups (Healthcare/Lifesciences) and as the Chair of the firm’s Corporate Department in Germany for several years. He draws on more than 25 years of experience to help German and international clients navigate complex M&A/PE transactions and corporate matters. Dr. Schneider advises major corporates and private equity firms across industries, including life sciences, healthcare, financial services, and real estate on major public and private M&A/PE transactions, as well as on stock corporation law.
Member of several supervisory boards and President of the American Chamber of Commerce, Northern Chapter.
He writes regularly on legal topics and has authored several legal handbooks, including a handbook on corporate law (Münchener Handbuch Gesellschaftsrecht) 2019, 5th edition, Grabitz/Hilf, and Law of the European Union 2021, 71st Edition.
Leading legal publications, including JUVE, Chambers, and Handelsblatt repeatedly rank Dr. Schneider as an outstanding M&A lawyer awarded among others as “One of the most renowned corporate/M&A lawyers in Germany” (Handelsblatt Best Lawyers) and “One of the Top 10 Legal Innovators of the Year in Europe” (Financial Times London Award).